Live feed
Filing
SC 13G/A
SC 13G/A0001839882-22-002943·During Matthew
Schedule 13G ownership disclosure
Ovid therapeutics, Inc.
Security class unavailable · CUSIP: 690469101
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,103,932
- Percent of class
- 4.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001839882-22-002943
- Form type
- SC 13G/A
- Filer
- During Matthew
- CIK
- CIK 1704631
- Filed
- Feb 14, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership